by Jason Wasserman MD PhD FRCPC
May 4, 2026
A cemento-ossifying fibroma (COF) is a noncancerous tumor that develops within the bones of the jaw, most often the mandible (lower jaw), and most often near the molar and premolar teeth. It is made up of fibrous tissue mixed with hard tissue that resembles either bone or cementum (the thin layer of mineralized tissue that normally covers the root of a tooth). Pathologists group lesions like this under the broader heading of “fibro-osseous lesions of the jaws” because they all share the same basic mix of fibrous and bone-like tissue. Cemento-ossifying fibroma is considered a true benign tumor — unlike fibrous dysplasia or cemento-osseous dysplasia, which are developmental conditions in which bone forms abnormally rather than truly growing as a mass.
Cemento-ossifying fibroma is most common in adults aged 20 to 40 and occurs roughly three to four times more often in women than in men. It tends to grow slowly over months to years and is often discovered as a painless swelling along the jaw, or by chance on a dental X-ray taken for another reason.
This article will help you understand the findings in your pathology report — what each term means and why it matters for your care.
The naming of this tumor has changed over the years, and you may encounter different terms in older reports:
The WHO also recognizes two related but distinct tumors under the broader heading of ossifying fibroma — juvenile trabecular ossifying fibroma and psammomatoid ossifying fibroma. These are described briefly later in the article. They behave differently and are treated differently from classic cemento-ossifying fibroma, so the specific name in your pathology report matters.
The cause of cemento-ossifying fibroma is not known in most cases. It is not linked to smoking, alcohol, dental hygiene, or any environmental exposure that has been clearly identified. The tumor is believed to arise from the periodontal ligament — the thin layer of connective tissue that anchors each tooth to the surrounding bone. Cells in this ligament can form both bone and cementum, which explains why the tumor contains a mixture of these two materials.
A small number of patients have a rare inherited form called familial gigantiform cementoma, which is described in its own section below. The great majority of cemento-ossifying fibromas are sporadic — meaning they arise out of nowhere and are not inherited or passed on to children.
Many cemento-ossifying fibromas cause no symptoms in the early stages and are discovered by chance on a routine dental X-ray. As the tumor grows, it slowly expands the surrounding bone and can produce:
The diagnosis is made after a tissue sample is examined under the microscope by a pathologist. A cemento-ossifying fibroma is usually first suspected on a dental X-ray, panoramic X-ray, or cone-beam CT, which shows a well-defined, round or oval lesion within the bone of the jaw. The classic appearance is a mixed dark (radiolucent) and white (radiopaque) mass with a sharp border — sometimes with a thin clear (radiolucent) rim around the edge. As the tumor matures, it tends to become more uniformly white on imaging because more bone and cementum-like material accumulates within it. The sharp border is one of the most important features that distinguishes a cemento-ossifying fibroma from fibrous dysplasia, which has poorly defined edges and merges into the surrounding normal bone. To confirm the diagnosis, an oral and maxillofacial surgeon performs a biopsy or removes the entire tumor in a single operation. The tissue is then sent to the laboratory.
Under the microscope, the pathologist looks for a mass made up of two main components. The first is a fibrous (scar-like) stroma containing spindle-shaped cells (fibroblasts) and thin collagenous strands. The second is mineralized material — a mix of bone trabeculae (small bars of bone) and ovoid, droplet-shaped calcifications that resemble cementum. The mix of these two types of mineralized material is the histologic signature of cemento-ossifying fibroma. The tumor is well-defined and often surrounded by a thin fibrous capsule that separates it from the normal bone, a key microscopic feature that distinguishes it from fibrous dysplasia. Once the diagnosis is confirmed, no additional testing is usually needed in adults with a typical isolated tumor.
The most important condition that cemento-ossifying fibroma must be distinguished from is fibrous dysplasia, a developmental disorder in which a portion of normal bone is gradually replaced by abnormal fibrous and bone tissue. Although both can appear as mixed dark-and-white lesions on imaging and both contain a mixture of fibrous tissue and bone under the microscope, they behave very differently and are managed very differently.
Cemento-ossifying fibroma is a true tumor with a sharp border. It can be removed cleanly from the surrounding bone, and complete removal is curative. Fibrous dysplasia, by contrast, is not a true tumor; it is a developmental abnormality of normal bone formation, has no clear border, and merges gradually into the surrounding bone. It cannot be removed cleanly, and surgery is usually limited to reshaping the affected bone for cosmetic or functional reasons rather than to complete excision. Fibrous dysplasia is also driven by a specific genetic change in the GNAS gene that is not present in cemento-ossifying fibroma. The distinction between these two diagnoses, therefore, has major implications for treatment, and your pathologist will examine the tumor carefully — often with the help of imaging — to make sure the right diagnosis is reached.
The WHO classification recognizes two related types of ossifying fibroma that occur in younger patients and behave more aggressively than classic cemento-ossifying fibroma. They share some microscopic features but are considered separate diagnoses.
If your pathology report uses one of these terms instead of “cemento-ossifying fibroma,” your treatment plan and follow-up schedule will be more intensive than the schedule outlined later in this article.
Familial gigantiform cementoma is a very rare inherited condition caused by mutations in a gene called ANO5. People with this condition develop multiple, large fibro-osseous tumors of the jaws starting in childhood or early adulthood. The lesions can grow to a substantial size and cause significant facial deformity. Because the condition is inherited, family members may also be affected, and referral to a medical geneticist or genetic counselor is recommended when this diagnosis is suspected. A single isolated cemento-ossifying fibroma in an adult with no family history is not part of this condition.
An important distinction your pathologist must make is between cemento-ossifying fibroma (which arises within the bone of the jaw) and the peripheral ossifying fibroma (which arises in the gum tissue overlying the bone). Despite the similar name, the two are fundamentally different. The peripheral ossifying fibroma is a reactive growth — a response to chronic local irritation from things like dental plaque, calculus, ill-fitting dental appliances, or rough fillings — rather than a true tumor. It looks like a small, firm, sometimes ulcerated bump on the gum and is treated by simple removal along with cleaning of any underlying source of irritation. If your pathology report uses the term “peripheral ossifying fibroma” or “peripheral cemento-ossifying fibroma,” you have a different and considerably less worrisome diagnosis than central cemento-ossifying fibroma.
The outlook for classic cemento-ossifying fibroma is excellent. It is benign, does not turn into cancer, and is curable by complete surgical removal. Recurrence is uncommon when the tumor has been completely removed because the well-defined capsule allows the surgeon to shell the tumor out cleanly from the surrounding bone. Recurrence rates are higher for the juvenile trabecular and psammomatoid types, which is why these variants are followed more closely. Long-term follow-up imaging is recommended for all patients to confirm bone healing and to monitor for the rare possibility of regrowth.
Treatment is led by an oral and maxillofacial surgeon, often working with a head and neck reconstructive surgeon and a dentist or prosthodontist for any later dental rehabilitation. The mainstay of treatment is surgery, and the goal is to remove the entire tumor cleanly from the surrounding bone.
After surgery, regular clinical examinations and panoramic X-rays or CT scans are performed for several years to confirm that the bone has healed and to watch for recurrence. Dental rehabilitation — including replacement of any teeth lost during surgery — can usually be planned once the bone has filled in.